SCHEMBL24683229

SCHEMBL24683229

CCOC(=O)c1c(N)sc2cc(OC)c(Br)cc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.56
▸ KMT2A Q03164 5/20 0.56
▸ MEN1 O00255 4/20 0.56
▸ ALOX15 P16050 3/20 0.56
▸ USP2 O75604 1/20 0.56
▸ LMNA P02545 3/20 0.54
▸ GAA P10253 2/20 0.54
▸ TSHR P16473 2/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ ALDH1A1 P00352 6/20 0.53
▸ NPSR1 Q6W5P4 2/20 0.52
▸ HPGD P15428 3/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ STING1 Q86WV6 2/20 0.48
▸ FHIT P49789 1/20 0.48
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ PRKCZ Q05513 1/20 0.46
▸ MAPK1 P28482 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24683234 0.82 KDM4E (0.59) MAPTKMT2AMEN1LMNATSHR
SCHEMBL30701675 0.82 KDM4E (0.59) MAPTKMT2AMEN1LMNATSHR
SCHEMBL2308619 0.79 MAPT (0.60) MAPTKMT2AMEN1ALOX15USP2
SCHEMBL6992051 0.76 GRM6 (0.57) MAPTKMT2AMEN1ALOX15USP2
SCHEMBL6996573 0.76 MAPT (0.57) MAPTKMT2AMEN1ALOX15USP2
SCHEMBL8429883 0.75 STING1 (0.49) MAPTKMT2ALMNATSHRL3MBTL1
SCHEMBL24683235 0.75 ALDH1A1 (0.47) MAPTKMT2AMEN1ALOX15USP2
SCHEMBL30701665 0.75 ALDH1A1 (0.47) MAPTKMT2AMEN1ALOX15USP2
SCHEMBL24683238 0.75 MAPT (0.57) MAPTKMT2AMEN1ALOX15USP2
SCHEMBL20353726 0.74 STING1 (0.73) MAPTLMNAGAAL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed
WO-2022173329-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Акционерное общество "Отисифарм" 2022-08-18 — — WO disclosed
WO-2022173329-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Акционерное общество "Отисифарм" 2022-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 MAPT 1064/4885KMT2A 734/4885MEN1 4654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback